Meeting
2018 ASCO-SITC Clinical Immuno-Oncology Symposium
TH1/17 hybrid CD4+ cells in bronchial alveolar lavage fluid from leukemia patients with checkpoint inhibitor-induced pneumonitis.
Authors
Sang Kim
The University of Texas, MD Anderson Cancer Center, Houston, TX
Sang Kim, Vickie Shannon, Ajay Sheshadri, Hagop M. Kantarjian, Guillermo Garcia-Manero, Jin Im, Farhad Ravandi, Aung Naing, Andrew Futreal, Naval Guastad Daver
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A
Track
Developmental Therapeutics,Genitourinary Cancer,Head and Neck Cancer,Lung Cancer,Melanoma/Skin Cancers,Gastrointestinal Cancer,Breast and Gynecologic Cancers,Combination Studies,Implications for Patients and Society,Miscellaneous Cancers,Oncolytic Viruses,Hematologic Malignancies
Sub Track
Biomarkers and Inflammatory Signatures
Citation
J Clin Oncol 36, 2018 (suppl 5S; abstr 204)
DOI
10.1200/JCO.2018.36.5_suppl.204
Abstract #
204
Poster Bd #
L2
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Metformin for chemoprevention of lung cancer in high-risk overweight or obese individuals.
First Author: Isra Nour
Poster
2024 ASCO Annual Meeting
Detection of immune-related adverse events among hospitalized patients using large language models.
First Author: Virginia H. Sun
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Correlation of exploration of immune profile and genomic with microsatellite stable/tumor mutational burden-low colorectal cancer.
First Author: Hassan Mohammed Abushukair
Poster
2023 ASCO Annual Meeting
Myeloablative fractionated busulfan-based conditioning regimen in patients with AML and MDS: Results of a randomized clinical trial comparing 2 fractionation schedules.
First Author: Uday R. Popat